000 01041 a2200265 4500
005 20250516225319.0
264 0 _c20150703
008 201507s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdu289
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBesse, B
245 0 0 _aPharmacogenomics in NSCLC: mostly unsexy but desperately needed.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cNov 2014
300 _a2099-2100 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
_xtrends
700 1 _aReck, M
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 25
_gno. 11
_gp. 2099-2100
856 4 0 _uhttps://doi.org/10.1093/annonc/mdu289
_zAvailable from publisher's website
999 _c24073498
_d24073498